SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/25/20 4D Pharma plc F-4 8:12M Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: F-4 Registration Statement by a Foreign Issuer - HTML 2.98M Securities for a Merger 2: EX-2.1 Plan of Acquisition, Reorganization, Arrangement, HTML 433K Liquidation or Succession 3: EX-2.2 Plan of Acquisition, Reorganization, Arrangement, HTML 95K Liquidation or Succession 4: EX-9.1 Voting Trust Agreement HTML 19K 5: EX-10.1 Material Contract HTML 81K 6: EX-10.2 Material Contract HTML 290K 7: EX-23.1 Consent of Expert or Counsel HTML 6K 8: EX-23.2 Consent of Expert or Counsel HTML 6K
tm2036619-1_f4_DIV_90-ex2-1 - none - 12.0942144s |
| | | | | A-2 | | | |
| | | | | A-2 | | | |
| | | | | A-2 | | | |
| | | | | A-3 | | | |
| | | | | A-3 | | | |
| | | | | A-3 | | | |
| | | | | A-3 | | | |
| | | | | A-4 | | | |
| | | | | A-5 | | | |
| | | | | A-5 | | | |
| | | | | A-5 | | | |
| | | | | A-5 | | | |
| | | | | A-5 | | | |
| | | | | A-6 | | | |
| | | | | A-6 | | | |
| | | | | A-6 | | | |
| | | | | A-7 | | | |
| | | | | A-7 | | | |
| | | | | A-8 | | | |
| | | | | A-9 | | | |
| | | | | A-9 | | | |
| | | | | A-9 | | | |
| | | | | A-9 | | | |
| | | | | A-10 | | | |
| | | | | A-10 | | | |
| | | | | A-10 | | | |
| | | | | A-10 | | | |
| | | | | A-10 | | | |
| | | | | A-10 | | | |
| | | | | A-11 | | | |
| | | | | A-11 | | | |
| | | | | A-11 | | | |
| | | | | A-11 | | | |
| | | | | A-11 | | | |
| | | | | A-11 | | | |
| | | | | A-11 | | | |
| | | | | A-12 | | |
| | | | | A-12 | | | |
| | | | | A-12 | | | |
| | | | | A-12 | | | |
| | | | | A-12 | | | |
| | | | | A-13 | | | |
| | | | | A-13 | | | |
| | | | | A-13 | | | |
| | | | | A-13 | | | |
| | | | | A-14 | | | |
| | | | | A-15 | | | |
| | | | | A-15 | | | |
| | | | | A-16 | | | |
| | | | | A-16 | | | |
| | | | | A-17 | | | |
| | | | | A-17 | | | |
| | | | | A-18 | | | |
| | | | | A-19 | | | |
| | | | | A-19 | | | |
| | | | | A-19 | | | |
| | | | | A-19 | | | |
| | | | | A-19 | | | |
| | | | | A-20 | | | |
| | | | | A-20 | | | |
| | | | | A-20 | | | |
| | | | | A-20 | | | |
| | | | | A-21 | | | |
| | | | | A-21 | | | |
| | | | | A-21 | | | |
| | | | | A-21 | | | |
| | | | | A-21 | | | |
| | | | | A-22 | | | |
| | | | | A-23 | | | |
| | | | | A-23 | | | |
| | | | | A-23 | | | |
| | | | | A-24 | | | |
| | | | | A-24 | | | |
| | | | | A-24 | | |
| | | | | A-24 | | | |
| | | | | A-25 | | | |
| | | | | A-25 | | | |
| | | | | A-26 | | | |
| | | | | A-26 | | | |
| | | | | A-27 | | | |
| | | | | A-27 | | | |
| | | | | A-27 | | | |
| | | | | A-27 | | | |
| | | | | A-28 | | | |
| | | | | A-28 | | | |
| | | | | A-29 | | | |
| | | | | A-30 | | | |
| | | | | A-30 | | | |
| | | | | A-31 | | | |
| | | | | A-31 | | | |
| | | | | A-32 | | | |
| | | | | A-32 | | | |
| | | | | A-32 | | | |
| | | | | A-33 | | | |
| | | | | A-33 | | | |
| | | | | A-33 | | | |
| | | | | A-34 | | | |
| | | | | A-35 | | | |
| | | | | A-35 | | | |
| | | | | A-35 | | | |
| | | | | A-35 | | | |
| | | | | A-36 | | | |
| | | | | A-36 | | | |
| | | | | A-37 | | | |
| | | | | A-37 | | | |
| | | | | A-37 | | | |
| | | | | A-46 | | | |
| | | | | A-46 | | | |
| | | | | A-46 | | |
| | | | | A-46 | | | |
| | | | | A-46 | | | |
| | | | | A-46 | | | |
| | | | | A-47 | | | |
| | | | | A-47 | | | |
| | | | | A-47 | | | |
| | | | | A-47 | | | |
| | | | | A-47 | | | |
| | | | | A-48 | | | |
| | | | | A-48 | | | |
| | | | | A-48 | | | |
| | | | | A-48 | | | |
| | | | | A-48 | | | |
| | | | | A-48 | | | |
| | | | | A-49 | | | |
| | | | | A-49 | | | |
| | | | | A-49 | | |
| Parent: | | |
4D PHARMA PLC
|
|
| | | |
By:
/s/ Duncan Peyton
Name: Duncan Peyton
Title: Chief Executive Officer |
|
| Merger Sub: | | |
DOLPHIN MERGER SUB LIMITED
|
|
| | | |
By:
/s/ Duncan Peyton
Name: Duncan Peyton
Title: Director |
|
| the Company: | | |
LONGEVITY ACQUISITION CORPORATION
|
|
| | | |
By:
/s/ Matthew Chen
Name: Matthew Chen
Title: Chairman and Chief Executive Officer |
|
This ‘F-4’ Filing | Date | Other Filings | ||
---|---|---|---|---|
5/29/21 | None on these Dates | |||
11/30/20 | ||||
Filed on: | 11/25/20 | |||
10/21/20 | ||||
8/31/20 | ||||
6/30/20 | ||||
5/27/20 | ||||
12/31/19 | ||||
12/31/18 | ||||
8/28/18 | ||||
8/23/18 | ||||
6/19/17 | ||||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/21/22 4D Pharma plc F-3 3:872K M2 Compliance LLC/FA 3/31/22 4D Pharma plc 20-F 12/31/21 82:13M M2 Compliance LLC/FA 10/07/21 4D Pharma plc F-1/A 90:15M M2 Compliance LLC/FA 9/14/21 4D Pharma plc F-1 9/13/21 76:9.2M M2 Compliance LLC/FA 4/30/21 4D Pharma plc 20-F/A 12/31/20 75:6.9M M2 Compliance LLC/FA 4/23/21 4D Pharma plc F-1 73:8.4M M2 Compliance LLC/FA 4/02/21 4D Pharma plc 20-F 12/31/20 77:7.1M M2 Compliance LLC/FA 2/24/21 4D Pharma plc F-4/A 4:11M Toppan Merrill/FA 2/19/21 4D Pharma plc F-4/A 4:11M Toppan Merrill/FA 2/16/21 4D Pharma plc F-4/A 12:12M Toppan Merrill/FA 1/28/21 4D Pharma plc F-4/A 17:100M Toppan Merrill/FA 1/08/21 4D Pharma plc F-4/A 7:12M Toppan Merrill/FA |